Metabolic Disease (371)
Metabolic diseases encompass a range of conditions that disrupt the body's ability to efficiently convert food into energy or regulate normal metabolic functions. Examples include diabetes, obesity, and disorders involving lipid metabolism or amino acid processing. Management often includes lifestyle modifications, medication, and, in certain instances, genetic therapies aimed at alleviating symptoms and enhancing overall well-being.
2-(3,6-dihydro-2H-pyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
tert-butyl (2,5-dioxopyrrolidin-3-yl)carbamate
(R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide
ethyl 5-bromo-1H-indole-2-carboxylate
tert-butyl (2S)-3-cyano-2-methyl-4-oxopiperidine-1-carboxylate
methyl 5-bromo-3-fluorothiophene-2-carboxylate
Ethyl 4-chloro-5-nitropicolinate
(R)-2-methoxypropan-1-amine
2-bromo-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one
ethyl 5-bromo-2-iodothiazole-4-carboxylate
2-(4-chloro-2-fluorophenyl)ethan-1-ol
2-amino-3-bromo-6-fluorobenzoic acid
(4-fluoro-3,5-dimethylphenyl)hydrazine hydrochloride
2-(1-(aminomethyl)cyclopropyl)acetonitrile hydrochloride
1-(difluoromethyl)-5-iodo-1H-imidazole
4-(hydroxymethyl)-3-methoxybenzonitrile
tert-butyl (S)-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridine-1(2H)-carboxylate
5-bromo-4-fluoro-1-methyl-1H-indazole
methyl 3,5-difluoro-4-nitrobenzoate
(R)-2-(bromomethyl)oxetane
tert-butyl 4-(6-chloropyridin-2-yl)piperidine-1-carboxylate
3,5-difluoro-4-nitrobenzoic acid
5-bromo-2-fluoro-1,3-dimethoxybenzene
4-iodo-2,2-dimethyltetrahydro-2H-pyran
5-bromo-4-fluoro-1H-indazole
methyl 3-fluoro-4-nitrobenzoate
Methyl 4-bromobenzo[b]thiophene-7-carboxylate
2-(benzyloxy)-6-bromopyridine
3-fluoro-4-(hydroxymethyl)benzonitrile
Total: 69